Publications by authors named "Shun-Cang Zhu"

Article Synopsis
  • * The study identifies circRNA hsa_circ_0008383 (cNEK6) as a potential biomarker for intrinsic gemcitabine resistance, as its high expression in patients correlates with increased glycolysis and the activation of the mTORC1 pathway.
  • * Combining gemcitabine with the mTORC1 inhibitor rapamycin could enhance treatment sensitivity for patients with elevated cNEK6 levels, offering a promising strategy to improve chemotherapy outcomes.
View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer with dismal prognosis due to distant metastasis, even in the early stage. Using RNA sequencing and multiplex immunofluorescence, here we find elevated expression of mixed lineage kinase domain-like pseudo-kinase (MLKL) and enhanced necroptosis pathway in PDAC from early liver metastasis T-stage (T1M1) patients comparing with non-metastatic (T1M0) patients. Mechanistically, MLKL-driven necroptosis recruits macrophages, enhances the tumor CD47 'don't eat me' signal, and induces macrophage extracellular traps (MET) formation for CXCL8 activation.

View Article and Find Full Text PDF

Intrahepatic cholangiocarcinoma (ICC) is characterized by its dense fibrotic microenvironment and highly malignant nature, which are associated with chemotherapy resistance and very poor prognosis. Although circRNAs have emerged as important regulators in cancer biology, their role in ICC remains largely unclear. Herein, a circular RNA, cPKM is identified, which is upregulated in ICC and associated with poor prognosis.

View Article and Find Full Text PDF